Urmărește-ne
RO
RO

Unul din obiectivele principale ale Life4me+ - să prevină apariția unor noi cazuri de infecție cu HIV, boli cu transmitere sexuală (TBS), hepatită C și tuberculoză

Aplicația permite stabilirea unei comunicări anonime între medici și persoane care au HIV. Îți permite să organizezi mai ușor programul de administrare a tratamentului și să setezi notificări personalizate și discrete

Toate știrile

Arhivă

✕
17 septembrie 2018
13094
HIV-positive Norwegians may not get modern antiretroviral drugs

HIV-positive Norwegians may not get modern antiretroviral drugs

The Kingdom of Norway, which has maintained the status of the state with the world's highest human development index (HDI) for the last ten years and is the third largest on the planet by nominal GDP per capita, is on the verge of a crisis of underfunding the drug people ...
17 septembrie 2018
10176
ViiV submits two-drug regimen for HIV in Europe

ViiV submits two-drug regimen for HIV in Europe

#ViiV Healthcare has submitted an application in Europe for a single-tablet, two-drug regimen of dolutegravir (DTG) and lamivudine (3TC) for the treatment of HIV-1 infection.
3 septembrie 2018
9983
Early birth and weight loss: why Africa refuses dolutegravir?

Early birth and weight loss: why Africa refuses dolutegravir?

Antiretroviral regimens (ART) based on protease inhibitors or nucleoside reverse transcriptase inhibitors can cause early childbirth and low birth weight. This is reported by Aidsmap with reference to the Journal of Acquired Immune Deficiency Syndromes.
31 august 2018
11070
FDA approved two new drugs for HIV treatment

FDA approved two new drugs for HIV treatment

The US Food and Drug Administration (FDA) has approved two new drugs for HIV treatment. This happened two months earlier than originally planned. The drugs are suitable for the treatment of adults with the most common strains of the virus and patients who have not received ...
30 august 2018
19247
Pharmacies in Finland began to sell rapid tests for HIV

Pharmacies in Finland began to sell rapid tests for HIV

In Finland, kits for testing HIV for blood drop, which can be used at home, were on sale. To get the result you need only wait 15 minutes.
28 august 2018
10687
EMA will consider the application for registration of the drug for the treatment of HIV infection Trogarzo

EMA will consider the application for registration of the drug for the treatment of HIV infection Trogarzo

On Tuesday, August 28, the Canadian pharmaceutical company Theratechnologies announced the filing of documents for the registration of the innovative drug for the treatment of HIV-1 with multiple drug resistance (MDR HIV-1) Trogarzo (ibalizumab) to the European Medicines ...
28 august 2018
9213
UNICEF: every hour 30 adolescents become infected with HIV. 2/3 - girls

UNICEF: every hour 30 adolescents become infected with HIV. 2/3 - girls

According to the report of the United Nations Children's Fund (UNICEF), adolescents 15-19 years, especially girls, are most affected by the global HIV / AIDS epidemic. According to the fund, every hour HIV is infected with about 30 teenagers, 20 of whom are girls.
27 august 2018
9844
Europe is close to achieving the goal of "90-90-90". But not all

Europe is close to achieving the goal of "90-90-90". But not all

According to a study published in the journal AIDS (JAIDS), Europe is close to achieving the goal of UNAIDS 90-90-90. According to the latest data, 81% of people living with HIV are aware of their status, 84% of them are receiving the necessary treatment, 88% of whom have ...
20 august 2018
12769
Former UN Secretary-General Kofi Annan died

Former UN Secretary-General Kofi Annan died

Former UN Secretary-General, Nobel Peace Prize winner Kofi Annan died at the age of 80. As Secretary General, he conducted UN reform, devoted a lot of time to the fight against HIV and implemented the UN Global Compact. In 2001, he made a proposal to create the Global Fund ...
18 august 2018
10709
Drug resistance to ARVT: new recommendations for testing and monitoring

Drug resistance to ARVT: new recommendations for testing and monitoring

Last month, a scientific journal on clinical infectious diseases published new recommendations of the International Antiviral Community (IAS) on testing and monitoring drug resistance to antiretroviral drugs used in HIV treatment.
Folosim cookies pentru a-ți îmbunătăți experiența pe acest site.
Apasând click pe oricare dintre butoane de pe acest site, îți exprimi acordul ca noi să folosim setările din cookies.